Concepedia

Tao Yin

TY

Statistics

Publications

65

Citations

5.1K

H-Index

37

Active since

2006

Affiliations

Huazhong University of Science and Technology(Current)

Union Hospital

Sichuan University

Union Hospital

Wuhan Union Hospital

Tao Yin is an author at Huazhong University of Science and Technology specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2006–2025

65

Publications

65

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study

Zhenggang Ren, Jianming Xu, Yuxian Bai et al. · The Lancet Oncology · 2021 · 1.1K citations

, , +13

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

, , +14

Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice

Ling Li, Linjiang Song, Xiaowei Liu et al. · ACS Nano · 2016 · 242 citations

, , +17

Up‐regulation of glycolysis promotes the stemness and <scp>EMT</scp> phenotypes in gemcitabine‐resistant pancreatic cancer cells

Hengqiang Zhao, Qingke Duan, Zhengle Zhang et al. · Journal of Cellular and Molecular Medicine · 2017 · 164 citations · Full text

, , +17

Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade

Zhengle Zhang, Qingke Duan, Hengqiang Zhao et al. · Cancer Letters · 2016 · 151 citations

, , +15

1–5 of 65